Friday, May 08, 2020 3:19:22 PM
PERFECTLY-TIMED NEWS: https://ih.advfn.com/stock-market/NYSE/laboratory-corporation-o-LH/stock-news/82389929/labcorp-is-scheduled-to-present-at-the-bank-of-ame
BUY LH:
[] AHEAD of the BANKS attending the conference
[] AHEAD of the Institutional Investors (some of whom appear to be buying already)
[] AHEAD of next week's ANTIBODY & in-home test-kit EXPANSION
[] And the REOPENING of the ECONOMY as May 15th sets off LARGE NUMBERS of workers being tested in compliance with NEW work-related employment rules per CDC & gov't.
EXPECTING a break-up into pre-Covid highs of $196.36 while MANY analysts are NOW predicting LH will break up through $200.00 & others have their price targets NORTH of $215.00
Looking at a MIN of 20% GAINS in a short period. LH has 97mm shares outstanding & is 93% institutionally-held. That leaves about 7mm shares avail in the float (generally speaking) & with Corona, COVANCE acquisition, data-mining, AI applications & diagnostic medical testing & administration LH is hitting on ALL CYLINDERS. The stock WILL REFLECT that value before long & ought to get to pre-Covid highs before the next Q imho if not by the end of the month!
LH
Recent LH News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2024 08:05:59 PM
- Ovia Health Expands Women's Health Offerings with Comprehensive Postpartum Experience • PR Newswire (US) • 09/18/2024 11:00:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/18/2024 10:12:36 AM
- LABCORP PRICES $650,000,000 IN 4.350% SENIOR NOTES DUE 2030, $500,000,000 IN 4.550% SENIOR NOTES DUE 2032 AND $850,000,000 IN 4.800% SENIOR NOTES DUE 2034 • PR Newswire (US) • 09/16/2024 10:35:00 PM
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 09/16/2024 09:30:56 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/16/2024 12:21:09 PM
- Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health • PR Newswire (US) • 09/16/2024 11:30:00 AM
- Labcorp to Speak at the Baird 2024 Global Healthcare Conference • PR Newswire (US) • 09/03/2024 08:09:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/09/2024 02:16:00 PM
- Labcorp Finalizes Acquisition of Select Assets of Invitae • PR Newswire (US) • 08/05/2024 11:00:00 AM
- Labcorp Receives FDA De Novo Marketing Authorization for PGDx elio™ plasma focus Dx • PR Newswire (US) • 08/02/2024 12:30:00 PM
- Labcorp Announces 2024 Second Quarter Results • PR Newswire (US) • 08/01/2024 10:57:00 AM
- Labcorp Expands Collaboration with Ultima Genomics to Advance Whole Genome Sequencing Applications and Oncology Testing Capabilities • PR Newswire (US) • 07/30/2024 11:00:00 AM
- Labcorp Declares Quarterly Dividend • PR Newswire (US) • 07/25/2024 10:59:00 AM
- Labcorp to Announce Second Quarter Financial Results on August 1, 2024 • PR Newswire (US) • 07/01/2024 11:00:00 AM
- Labcorp Launches Global Trial Connect to Accelerate Clinical Trials • PR Newswire (US) • 06/17/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/10/2024 12:52:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 11:41:13 AM
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 06/03/2024 09:23:56 PM
- Labcorp Announces New Strategic Service Offerings within Precision Oncology Portfolio • PR Newswire (US) • 06/03/2024 11:00:00 AM
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/30/2024 05:18:28 PM
- Labcorp to Present Multiple Abstracts across Precision Oncology at the 2024 ASCO Annual Meeting • PR Newswire (US) • 05/30/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2024 11:04:15 AM
- Labcorp to Speak at the 44th Annual William Blair Growth Stock Conference • PR Newswire (US) • 05/28/2024 10:59:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/17/2024 08:57:17 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM